MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms
出版年份 2012 全文链接
标题
MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms
作者
关键词
-
出版物
FASEB JOURNAL
Volume 26, Issue 7, Pages 3032-3041
出版商
FASEB
发表日期
2012-03-30
DOI
10.1096/fj.11-201855
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- High expression of transcriptional coactivator p300 correlates with aggressive features and poor prognosis of hepatocellular carcinoma
- (2011) Mei Li et al. Journal of Translational Medicine
- Role of miR-224 in hepatocellular carcinoma: a tool for possible therapeutic intervention?
- (2011) Yu Wang et al. Epigenomics
- Core promoter structure and genomic context reflect histone 3 lysine 9 acetylation patterns
- (2010) Anton Kratz et al. BMC GENOMICS
- Virtual Ligand Screening of the p300/CBP Histone Acetyltransferase: Identification of a Selective Small Molecule Inhibitor
- (2010) Erin M. Bowers et al. CHEMISTRY & BIOLOGY
- MiR-222 Overexpression Confers Cell Migratory Advantages in Hepatocellular Carcinoma through Enhancing AKT Signaling
- (2010) Q. W-L. Wong et al. CLINICAL CANCER RESEARCH
- Serum microRNA characterization identifiesmiR-885-5pas a potential marker for detecting liver pathologies
- (2010) Junhao Gui et al. CLINICAL SCIENCE
- Lethal-7 is down-regulated by the hepatitis B virus x protein and targets signal transducer and activator of transcription 3
- (2010) Yu Wang et al. JOURNAL OF HEPATOLOGY
- MicroRNA-224 Is Involved in Transforming Growth Factor-β-Mediated Mouse Granulosa Cell Proliferation and Granulosa Cell Function by Targeting Smad4
- (2010) Guidong Yao et al. MOLECULAR ENDOCRINOLOGY
- miR-21as a key regulator of oncogenic processes
- (2009) S. Duygu Selcuklu et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- MicroRNA-101, Down-regulated in Hepatocellular Carcinoma, Promotes Apoptosis and Suppresses Tumorigenicity
- (2009) H. Su et al. CANCER RESEARCH
- HAT–HDAC interplay modulates global histone H3K14 acetylation in gene-coding regions during stress
- (2009) Anna Johnsson et al. EMBO REPORTS
- Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated
- (2009) Xiao-Hui Huang et al. HEPATOLOGY RESEARCH
- MicroRNA-224is upregulated in HepG2 cells and involved in cellular migration and invasion
- (2009) Qiong Li et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration
- (2009) X Li et al. ONCOGENE
- Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
- (2009) C Coulouarn et al. ONCOGENE
- miR-221 overexpression contributes to liver tumorigenesis
- (2009) P. Pineau et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Elevated Expression of the miR-17–92 Polycistron and miR-21 in Hepadnavirus-Associated Hepatocellular Carcinoma Contributes to the Malignant Phenotype
- (2008) Erin Connolly et al. AMERICAN JOURNAL OF PATHOLOGY
- Association of MicroRNA Expression in Hepatocellular Carcinomas with Hepatitis Infection, Cirrhosis, and Patient Survival
- (2008) J. Jiang et al. CLINICAL CANCER RESEARCH
- Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma
- (2008) Shunsuke Ura et al. HEPATOLOGY
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
- (2008) Yannick Ladeiro et al. HEPATOLOGY
- Profiling MicroRNA Expression in Hepatocellular Carcinoma Reveals MicroRNA-224 Up-regulation and Apoptosis Inhibitor-5 as a MicroRNA-224-specific Target
- (2008) Yu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNA and cancer - focus on apoptosis
- (2008) Yu Wang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started